What is Moximed?
Founded in 2006 and headquartered in Fremont, California, Moximed specializes in the development and manufacturing of surgical equipment designed for the treatment of osteoarthritis. The company operates within the competitive medical technology landscape, focusing on innovative solutions to address the needs of orthopedic surgeons and patients suffering from degenerative joint conditions. Moximed's product portfolio aims to enhance surgical outcomes and improve patient quality of life through advanced device technology.
How much funding has Moximed raised?
Moximed has raised a total of $239.8M across 6 funding rounds:
Private Equity
$10M
Series A
$45.8M
Series B
$33M
Series C
$50M
Series C
$40M
Series D
$61M
Private Equity (2009): $10M, investors not publicly disclosed
Series A (2011): $45.8M led by GBS Venture Partners, Frazier Healthcare Partners, and Gilde Healthcare
Series B (2015): $33M supported by GBS Venture Partners, Vertex Holdings, Gilde Healthcare, Morgenthaler Private Equity, and New Enterprise Associates
Series C (2017): $50M featuring Gilde Healthcare, NEA, GBS Venture Partners, Vertex Healthcare, Morgenthaler Private Equity, and Advent Venture Partners
Series C (2022): $40M backed by GBS Venture Partners, Gilde Healthcare, New Enterprise Associates, Future Fund, Advent Life Sciences, and Vertex Healthcare
Series D (2024): $61M with participation from Elevage Medical Technologies, Gilde Healthcare, and New Enterprise Associates
Key Investors in Moximed
Gilde Healthcare
Gilde Healthcare is a specialized healthcare investment firm managing over €1.4 billion across three fund strategies: Venture & Growth in Healthcare, Private Equity in Healthcare, and Private Equity in Climate Solutions. The firm focuses on investing in businesses that enable better care at lower costs and address planetary challenges through energy transition, biodiversity, and waste management. With a portfolio that includes healthtech, therapeutics, and climate-related companies, Gilde Healthcare aims to support impactful solutions in both sectors. Headquartered in Utrecht, the Netherlands, with offices in Frankfurt, Germany, and Boston, USA, Gilde Healthcare serves clients in the healthcare and climate sectors.
New Enterprise Associates
Established in 1977 and headquartered in Menlo Park, California. New Enterprise Associates(NEA) is a venture capital firm focused on helping entrepreneurs build businesses.
GBS Venture Partners
GBS Venture Partners is a venture capital firm that focuses on investing in innovative healthcare companies. They aim to support entrepreneurs in the development of groundbreaking medical solutions. Their portfolio includes companies involved in pharmaceuticals and medical devices, targeting various health conditions. GBS Venture Partners is dedicated to advancing healthcare through strategic investments and partnerships.
What's next for Moximed?
The recent major strategic investment signals Moximed's readiness for its next phase of growth, likely involving scaling manufacturing capabilities, expanding market reach, and further research and development into next-generation osteoarthritis treatments. The substantial enterprise-level funding accumulated over its history indicates a strong investor confidence in Moximed's business model and its potential to capture a significant share of the orthopedic surgical equipment market. Future strategic initiatives may include partnerships, acquisitions, or further product line extensions to solidify its position as a leader in orthopedic innovation.
See full Moximed company page
